By investigating the association of the rs1042522 SNP of the TP53 gene in cancer tissues, primary tumor cultures, and serum samples, our study aims to provide additional evidence of the association of this SNP with prostate cancer risk in a European Caucasian population. This evidence concerns the gene TP53 and prostate carcinoma.